Histiocytosis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Histiocytosis Classification and external resources | |
| ICD-10 | C96.1, D76.0 |
|---|---|
| ICD-9 | 202.3, 277.89 |
| eMedicine | ped/1997 |
| MeSH | D015614 |
|
WikiDoc Resources for Histiocytosis | |
|
Articles | |
|---|---|
|
Most recent articles on Histiocytosis Most cited articles on Histiocytosis | |
|
Media | |
|
Powerpoint slides on Histiocytosis | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Histiocytosis at Clinical Trials.gov Trial results on Histiocytosis Clinical Trials on Histiocytosis at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Histiocytosis NICE Guidance on Histiocytosis
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Histiocytosis Discussion groups on Histiocytosis Patient Handouts on Histiocytosis Directions to Hospitals Treating Histiocytosis Risk calculators and risk factors for Histiocytosis
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Histiocytosis | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
In medicine, histiocytosis is an excessive number of histiocytes,[1] that is an excessive number of tissue macrophages, and is typically used to refer to a group of rare diseases which share this as a characteristic. Occasionally and confusingly it is sometimes used to refer to individual diseases.
According to the Histiocytosis Association of America, 1 in 200,000 children in the United States are born with histiocytosis each year.[1] HAA also states that most of the people diagnosed with histiocytosis are children under the age of 10. The University of California, San Francisco, states that the disease usually occurs from birth to age 15.[1]
Histiocytosis (and malignant histiocytosis) are both important in veterinary as well as human pathology.
Presentation
Histiocytosis is frequently associated with diabetes insipidus, even after several years of diagnosis and successful therapy.
Classification, and relationships to other conditions
There are competing systems for classifying histiocytoses. According to the 1999 classification proposed by the World Health Organization, they can be divided into three categories.[1][1]. However, the classifications in ICD10 and MeSH are slightly different, as shown below:
| Name | WHO | ICD10 | MeSH |
| Langerhans cell histiocytosis (LCH) | I | D76.0 | Langerhans-cell histiocytosis |
| Juvenile xanthogranuloma (JXG) | II | D76.3 | non-Langerhans-cell histiocytosis |
| Hemophagocytic lymphohistiocytosis (HLH) | II | D76.1 | non-Langerhans-cell histiocytosis |
| Niemann-Pick disease | - | E75.2 | non-Langerhans-cell histiocytosis |
| Sea-blue histiocyte syndrome | - | - | non-Langerhans-cell histiocytosis |
| Acute monocytic leukemia | III | C93.0 | malignant histiocytic disorders |
| Malignant histiocytosis | III | C96.1 | malignant histiocytic disorders |
| Erdheim-Chester disease | - | C96.1 | malignant histiocytic disorders |
Types of LCH have also been known as "Eosinophilic Granuloma", "Hand-Schuller-Christian Disease", "Letterer-Siwe Disease", and "Histiocytosis X". (See LCH history for details).
Common treatments
- Chemotherapy
- Cladribine or 2CDA or leustatin
- Etoposide
- Vinblastine or Velban
Organizations
Patients and families can gain some support by contacting patient organisations such as the Histiocytosis Association of America ([3]) or the Histiocytosis Research Trust ([4]). The Histiocytosis Association of America has several stable and proven treatment protocols available only for physicians ([5]).
References
WikiDoc Research Resources for Histiocytosis | |
|---|---|
| Articles on Histiocytosis | Most recent articles on Histiocytosis • Most cited articles on Histiocytosis • Review articles on Histiocytosis • Articles on Histiocytosis in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Histiocytosis | Powerpoint slides on Histiocytosis • Images of Histiocytosis • Photos of Histiocytosis • Podcasts & MP3s on Histiocytosis • Videos on Histiocytosis |
| Evidence Based Medicine Regarding Histiocytosis | Cochrane Collaboration on Histiocytosis • Bandolier on Histiocytosis • TRIP on Histiocytosis |
| Cost Effectiveness of Histiocytosis | Cost Effectiveness of Histiocytosis |
| Clinical Trials Involving Histiocytosis | Ongoing Trials on Histiocytosis at Clinical Trials.gov • Trial results on Histiocytosis • Clinical Trials on Histiocytosis at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Histiocytosis | US National Guidelines Clearinghouse on Histiocytosis • NICE Guidance on Histiocytosis • NHS PRODIGY Guidance • FDA on Histiocytosis • CDC on Histiocytosis |
| Textbook Information on Histiocytosis | Books and Textbook Information on Histiocytosis |
| Pharmacology Resources on Histiocytosis | Dosing of Histiocytosis • Drug interactions with Histiocytosis • Side effects of Histiocytosis • Allergic reactions to Histiocytosis • Overdose information on Histiocytosis • Carcinogenicity information on Histiocytosis • Histiocytosis in pregnancy • Pharmacokinetics of Histiocytosis • |
| Genetics, Pharmacogenomics, and Proteinomics of Histiocytosis | Genetics of Histiocytosis • Pharmacogenomics of Histiocytosis • Proteomics of Histiocytosis |
| Newstories on Histiocytosis | Histiocytosis in the news • Be alerted to news on Histiocytosis • News trends on Histiocytosis |
| Commentary on Histiocytosis | Blogs on Histiocytosis |
| Patient Resources on Histiocytosis | Patient resources on Histiocytosis • Discussion groups on Histiocytosis • Patient Handouts on Histiocytosis • Directions to Hospitals Treating Histiocytosis • Risk calculators and risk factors for Histiocytosis |
| Healthcare Provider Resources on Histiocytosis | Symptoms of Histiocytosis • Causes & Risk Factors for Histiocytosis • Diagnostic studies for Histiocytosis • Treatment of Histiocytosis |
| Continuing Medical Education (CME) Programs on Histiocytosis | CME Programs on Histiocytosis |
| International Resources on Histiocytosis | Histiocytosis en Espanol • Histiocytosis en Francais |
| Business Resources on Histiocytosis | Histiocytosis in the Marketplace • Patents on Histiocytosis |
| Informatics Resources on Histiocytosis | List of terms related to Histiocytosis |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

